Goldman Sachs’s Adaptive Biotechnologies ADPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$22.5M Sell
1,927,443
-78,001
-4% -$909K ﹤0.01% 1695
2025
Q1
$14.9M Sell
2,005,444
-232,682
-10% -$1.73M ﹤0.01% 1921
2024
Q4
$13.4M Buy
2,238,126
+488,979
+28% +$2.93M ﹤0.01% 2106
2024
Q3
$8.96M Buy
1,749,147
+701,135
+67% +$3.59M ﹤0.01% 2345
2024
Q2
$3.79M Buy
1,048,012
+421,291
+67% +$1.53M ﹤0.01% 2809
2024
Q1
$2.01M Sell
626,721
-177,339
-22% -$569K ﹤0.01% 3198
2023
Q4
$3.94M Sell
804,060
-893,114
-53% -$4.38M ﹤0.01% 2766
2023
Q3
$9.25M Sell
1,697,174
-452,056
-21% -$2.46M ﹤0.01% 2043
2023
Q2
$14.4M Buy
2,149,230
+649,493
+43% +$4.36M ﹤0.01% 1780
2023
Q1
$13.2M Buy
1,499,737
+209,162
+16% +$1.85M ﹤0.01% 1805
2022
Q4
$9.86M Sell
1,290,575
-616,014
-32% -$4.71M ﹤0.01% 2146
2022
Q3
$13.6M Buy
1,906,589
+566,107
+42% +$4.03M ﹤0.01% 1896
2022
Q2
$10.8M Buy
1,340,482
+164,380
+14% +$1.33M ﹤0.01% 2071
2022
Q1
$16.3M Sell
1,176,102
-143,271
-11% -$1.99M ﹤0.01% 1859
2021
Q4
$37M Buy
1,319,373
+47,975
+4% +$1.35M 0.01% 1331
2021
Q3
$43.2M Sell
1,271,398
-107,367
-8% -$3.65M 0.01% 1187
2021
Q2
$56.3M Buy
1,378,765
+247,166
+22% +$10.1M 0.01% 985
2021
Q1
$45.6M Buy
1,131,599
+272,217
+32% +$11M 0.01% 1090
2020
Q4
$50.8M Sell
859,382
-392,043
-31% -$23.2M 0.01% 955
2020
Q3
$60.9M Buy
1,251,425
+121,232
+11% +$5.9M 0.02% 749
2020
Q2
$54.7M Buy
1,130,193
+522,605
+86% +$25.3M 0.02% 802
2020
Q1
$16.9M Buy
607,588
+157,695
+35% +$4.38M 0.01% 1437
2019
Q4
$13.5M Buy
449,893
+202,183
+82% +$6.05M ﹤0.01% 1870
2019
Q3
$7.66M Buy
247,710
+95,581
+63% +$2.95M ﹤0.01% 2082
2019
Q2
$7.35M Buy
+152,129
New +$7.35M ﹤0.01% 2116